Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cabazitaxel”

115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 115 results

Early research (Phase 1)Study completedNCT01755390
What this trial is testing

A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Sanofi 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592237
What this trial is testing

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
M.D. Anderson Cancer Center 120
Early research (Phase 1)Study completedNCT01324583
What this trial is testing

Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Sanofi 48
Large-scale testing (Phase 3)Study completedNCT01308567
What this trial is testing

Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sanofi 1,168
Testing effectiveness (Phase 2)Study completedNCT01438307
What this trial is testing

Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Stage IV NSCLCMetastatic NSCLC
University of Alabama at Birmingham 28
Testing effectiveness (Phase 2)Study completedNCT01518283
What this trial is testing

Study of Weekly Cabazitaxel for Advanced Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Spanish Oncology Genito-Urinary Group 74
Testing effectiveness (Phase 2)Ended earlyNCT01934894
What this trial is testing

Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases

Who this might be right for
Metastatic Breast Cancer With Intracranial Metastases
SCRI Development Innovations, LLC 11
Testing effectiveness (Phase 2)Study completedNCT03114254
What this trial is testing

A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis

Who this might be right for
Penile Neoplasm
University Hospitals Bristol and Weston NHS Foundation Trust 17
Testing effectiveness (Phase 2)Study completedNCT01541007
What this trial is testing

A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Jeffrey Yachnin M.D., PhD. 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890832
What this trial is testing

Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, MCRPC
Jina Pharmaceuticals Inc. 75
Testing effectiveness (Phase 2)Study completedNCT01558219
What this trial is testing

Second-line Chemotherapy in Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Tampere University Hospital 60
Post-approval studies (Phase 4)Study completedNCT02074137
What this trial is testing

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Sanofi 10
Testing effectiveness (Phase 2)Study completedNCT01500720
What this trial is testing

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Sanofi 179
Testing effectiveness (Phase 2)Study completedNCT04495179
What this trial is testing

AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.

Who this might be right for
Progressive Metastatic Castrate-Resistant Prostate Cancer
AstraZeneca 30
Large-scale testing (Phase 3)Looking for participantsNCT03258320
What this trial is testing

A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients

Who this might be right for
Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine 300
Testing effectiveness (Phase 2)Ended earlyNCT01001221
What this trial is testing

Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor

Who this might be right for
Neoplasms, Malignant
Sanofi 19
Testing effectiveness (Phase 2)Study completedNCT01174368
What this trial is testing

Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T

Who this might be right for
Prostate Cancer
The Rogosin Institute 1
Large-scale testing (Phase 3)UnknownNCT01830231
What this trial is testing

Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)

Who this might be right for
Urothelium Transitional Cell Carcinoma
Associació per a la Recerca Oncologica, Spain 372
Testing effectiveness (Phase 2)Study completedNCT01852578
What this trial is testing

Cabazitaxel in Relapsed and Metastatic NSCLC

Who this might be right for
NSCLC
Hellenic Oncology Research Group 46
Large-scale testing (Phase 3)Active Not RecruitingNCT01952223
What this trial is testing

A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse

Who this might be right for
Adenocarcinoma of ProstateProgression of Prostate Cancer
UNICANCER 761
Load More Results